-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Venous thromboembolism (VTE) is very common in cancer patients.
thrombusStomach cancer
The study included patients with resectable gastric cancer who received three cycles of epirubicin, cisplatin or oxaliplatin and capecitabine (ECC/EOC) before surgery
Heart blood vessels
The results showed that 78 of 781 patients (10%) developed VTE during preoperative chemotherapy
In summary, the results of this study show that high BMI and previous history of VTE are independent risk factors for VTE during preoperative chemotherapy in patients with resectable gastric cancer
Original source:
Astrid E Slagter, et al.
Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
in this message